Hereditary spherocytosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Amar Morani (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
As with most inherited hemolytic anemias, treatment is directed at preventing or minimizing complications of chronic hemolysis and anemia. There are no specific treatments directed at the underlying red blood cell (RBC) membrane defect. | |||
==Medical Therapy== | ==Medical Therapy== | ||
Revision as of 10:15, 27 July 2018
|
Hereditary spherocytosis Microchapters |
|
Differentiating Hereditary spherocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hereditary spherocytosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Hereditary spherocytosis medical therapy |
|
Risk calculators and risk factors for Hereditary spherocytosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
As with most inherited hemolytic anemias, treatment is directed at preventing or minimizing complications of chronic hemolysis and anemia. There are no specific treatments directed at the underlying red blood cell (RBC) membrane defect.